R. David Hoover - 29 Nov 2024 Form 4 Insider Report for Elanco Animal Health Inc (ELAN)

Role
Director
Signature
/s/ Amy C. Seidel, as Attorney-in-Fact for R. David Hoover
Issuer symbol
ELAN
Transactions as of
29 Nov 2024
Net transactions value
$0
Form type
4
Filing time
03 Dec 2024, 17:07:40 UTC
Previous filing
08 Mar 2024
Next filing
07 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELAN Common Stock Award $0 +18,169 +23% $0.000000 96,459 29 Nov 2024 Direct F1
holding ELAN Common Stock 185,000 29 Nov 2024 Revocable Trust
holding ELAN Common Stock 15,920 29 Nov 2024 Suzanne A. Hoover Revocable Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of deferred stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors.